![Ypke van Oosterhout](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Ypke van Oosterhout
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Vorstandsvorsitzender | 01.01.2009 | - | |
Gründer | 01.01.2009 | - |
Karriereverlauf von Ypke van Oosterhout
Statistik
International
Niederlande | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Börse
- Insiders
- Ypke van Oosterhout
- Erfahrung